Get Smart! Experts Consider These Two Factors when Choosing the Right CDMO for Developing Injectable Medicines

When it comes to launching a new injectable medicine, there's no cheat sheet or crystal ball. But there is a smart way forward. If you're a biopharma innovator staring down a maze of timelines, compliance hurdles, and tight budgets, it’s time to get smart about your Contract Development and Manufacturing Organization (CDMO) partner. The…

Cancer, Chemistry & Clinicals: Where Injectable Innovation Meets Global Aspiration

Cancer research has always been a high-stakes game of precision, persistence, and possibility. In today’s world of cutting-edge biologics and targeted therapies, the spotlight is increasingly shifting toward one key delivery method: injectables. Whether it’s monoclonal antibodies, antibody-drug conjugates, cytokines, or next-generation immunotherapies, these life-saving innovations often hinge on the…

Pharmaceutical Formulation Development: Science, Strategy & Smarter Solutions

When it comes to pharmaceutical formulation development, let’s face it - this isn’t amateur hour. Turning promising active ingredients into stable, injectable drug products takes more than luck and a lab coat. It requires chemistry, strategy, regulatory finesse, and a borderline-obsessive attention to detail. In an industry where time-to-clinic is…

Breaking News: Singota Solutions Expands Again with New Switzerland Facility

From the rolling green hills of southern Switzerland comes Singota Solutions’ latest announcement: and it's one that packs a punch. This ever-growing CDMO just unveiled our newest international addition: a cutting-edge, solar-powered, three-floor pharmaceutical storage and logistics facility located in the heart of Balerna, Switzerland. Perfectly situated near the Swiss-Italian…

Posts pagination